BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35866458)

  • 21. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
    Goldstein RE; Netterville JL; Burkey B; Johnson JE
    Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
    Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
    Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Malignancy Rates in Thyroid Nodules: How to Counsel Patients on Extent of Surgery.
    Lindeman BM; Nehs MA; Angell TE; Alexander EK; Gawande AA; Moore FD; Doherty GM; Cho NL
    Ann Surg Oncol; 2019 Jan; 26(1):93-97. PubMed ID: 30341576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
    Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid fine-needle aspiration cytology: performance data of neoplastic and malignant cases as identified from 1558 responses in the ASCP Non-GYN Assessment program thyroid fine-needle performance data.
    Eilers SG; LaPolice P; Mukunyadzi P; Kapur U; Wendel Spiczka A; Shah A; Saleh H; Adeniran A; Nunez A; Balachandran I; Clark JJ; Lemon L
    Cancer Cytopathol; 2014 Oct; 122(10):745-50. PubMed ID: 24913410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What really is an indeterminate FNA thyroid nodule?
    Pezzolla A; Lattarulo S; Madaro A; Docimo G; Lacalendola E; Prete F; Marzaioli R
    Ann Ital Chir; 2017; 88():275-281. PubMed ID: 28632145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic features of a case of mixed medullary and follicular cell-derived thyroid carcinoma with review of the literature.
    Chambers M; Tafe LJ; Gutmann EJ; Kerr DA
    Diagn Cytopathol; 2021 Mar; 49(3):E125-E129. PubMed ID: 32936534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
    Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
    Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
    Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
    [No Abstract]   [Full Text] [Related]  

  • 32. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 34. Fine needle aspiration of secondary synovial sarcoma of the thyroid gland.
    Murro D; Slade JM; Syed S; Gattuso P
    Diagn Cytopathol; 2015 Nov; 43(11):928-32. PubMed ID: 26304470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case with poorly differentiated follicular carcinoma of the thyroid produced and secreted CEA].
    Kobayashi K; Yokozawa T; Ito Y; Matsuzuka H; Kuma K; Miyauchi A; Kakudo K
    Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):488-90. PubMed ID: 12854498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can cytology and the Thyroid Imaging, Reporting, and Data System (TI-RADS) identify noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) before surgery?
    Yang GCH; Fried KO; Scognamiglio T
    J Am Soc Cytopathol; 2020; 9(3):159-165. PubMed ID: 32111537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.